Tirzepatide, a dual-agonist peptide, has shown significant results with a 22.5% weight loss over 72 weeks at a 15 mg dose (Jastreboff et al., NEJM), making it one of the most effective therapies for obesity
Disclaimer: *Topical or External use only
PAS tel no +44 (0)1656 769 717 answerphone Based in UK but has members from around the world
Based on the UK Biobank data, genetic prediction of vitamin B12 concentrations showed no association with liver enzymes in the main analysis (IVW-multiplicative random effects)
We appreciate a commenter's position that there are existing CMS programs that drive patient safety improvement and that additional efforts may be conflicting, but we respectfully disagree and believe that further emphasis of patient safety in the Overall Hospital Quality Star Rating aligns with other efforts to improve patient safety including through HACRP
They can assess your health and provide safe and effective treatment recommendations